These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 25384184

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M, Lewis S, Premawardhana L, Dayan CM, Taylor PN, Okosieme OE.
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
    Sato H, Minagawa M, Sasaki N, Sugihara S, Kazukawa I, Minamitani K, Wataki K, Konda S, Inomata H, Sanayama K, Kohno Y.
    J Pediatr Endocrinol Metab; 2011 Jun; 24(5-6):257-63. PubMed ID: 21823520
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S, Tzotzas T, Kaltsas T, Krassas GE.
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [Abstract] [Full Text] [Related]

  • 28. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H, Miyauchi A, Miyawaki N, Imagawa J.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
    Nagayama Y, Eishima K, Hirayu H, Yamashita S, Ashizawa K, Matsuo K, Inoue S, Harakawa S, Morita S, Izumi M.
    Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
    [Abstract] [Full Text] [Related]

  • 34. Toxicological considerations for antithyroid drugs in children.
    Karras S, Tzotzas T, Krassas GE.
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
    [Abstract] [Full Text] [Related]

  • 35. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK, Yoo WS, Kim DW, Chung HK.
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [Abstract] [Full Text] [Related]

  • 36. The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials.
    Tan S, Chen L, Jin L, Fu X.
    Medicine (Baltimore); 2021 Jul 30; 100(30):e26707. PubMed ID: 34397700
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.